Approval · Notice of Compliance 20209 · 2017
CONRAY 30: Notice of Compliance 20209
Issued December 27, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20209
- Date
- December 27, 2017
- Company
- Liebel-Flarsheim Canada IncPointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional site for the manufacture of CONRAY and additional supplier of the Active Pharmaceutical (Iothalamic Acid USP). Changes to the "PRESCRIBING INFORMATION" format to the newest PM format (2016), which now includes Part I, Part II and Part III.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CONRAY 30 | Not yet assigned | — |
| CONRAY 43 | Not yet assigned | — |
| CONRAY 60 | Not yet assigned | — |
Medicinal ingredients
- IOTHALAMIC ACID 231.8 MG per ML
- IOTHALAMIC ACID 331.8 MG per ML
- IOTHALAMIC ACID 462 MG per ML